The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is now certified to offer a groundbreaking treatment for non-Hodgkin lymphoma, in which a patient’s own immune cells are genetically engineered to recognize and attack the cancer.
{iframe}https://www.umms.org/umgccc/news/2018/administer-car-t-cell-therapy-lymphoma{/iframe}